Nástroje

iconicon Akciový screener
iconicon Kalendář zisků
iconicon Super investoři

Ostatní

iconicon Návod
IČ: 19940963

5. května 521, 501 01 Turnov
Zásady GDPR
Podmínky služby
Všechna práva vyhrazena @ 2024, Fundamenty.cz
Proudly created by draftspot.net
Cytokinetics, Incorporated
Cytokinetics, Incorporated
CYTK
Valuace
70
Růst
0
Zdraví
75
Cena
$ 61.81
Dnes
--0.86 (-1.35%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
7.4B
Obrat
0B
Zisk
-1B
Aktiva
1B
Dluh
1B
ROE
144%
ROA
-52%
PE
-10
PS
86
Cena 1R
29-71
⌀ Cena
47.17
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
26-02-2026
Poslední dividenda

Profil

Cytokinetika, Incorporated, biofarmaceutická společnost v pozdním stadiu, se zaměřuje na objevování, vývoj a komercializaci svalových aktivátorů a inhibitorů jako potenciální léčby vysilujících onemocnění. Společnost vyvíjí malé molekulární lékové kandidáty primárně navržené tak, aby ovlivňovaly svalovou funkci a kontraktilitu. Mezi jeho léčivé přípravky patří omecamtiv mecarbil, nový aktivátor srdečního myozinu, který je v klinické studii fáze III u pacientů se srdečním selháním, a reldesemtiv, troponinový aktivátor kosterního svalstva, který je v klinické studii fáze III k léčbě amyotrofické laterální sklerózy a spinální svalové atrofie. Společnost také vyvíjí CK- 136, nový aktivátor srdečního troponinu, který je v klinické studii fáze I; aficamten, nový inhibitor srdečního myosinu, který je v klinické studii fáze III pro léčbu pacientů se symptomatickou obstrukční hypertrofickou kardiomyopatií; a CK- 3772271, malý molekulární inhibitor srdečního myosinu, který je v klinické studii fáze I. Společnost Cytokinetics, Incorporated má strategické spojenectví s Astellas Pharma Inc. Společnost byla založena v roce 1997 a sídlí v Jižním San Francisku v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
498
Založení
2004-04-30
Adresa
350 Oyster Point Boulevard
CEO
Robert I. Blum
Web
www.cytokinetics.com

Podobné společnosti

MRUS
Merus N.V.
$ 95.23
- $ 0.01
NUVL
Nuvalent, Inc.
$ 91.82
- $ 1.54
AXSM
Axsome Therapeutics, Inc.
$ 137.94
- $ 0.21
RYTM
Rhythm Pharmaceuticals, Inc.
$ 96.93
- $ 3.37
HALO
Halozyme Therapeutics, Inc.
$ 68.88
+ $ 0.64
JAZZ
Jazz Pharmaceuticals plc
$ 132.79
+ $ 1.63
CORT
Corcept Therapeutics Incorporated
$ 72.96
- $ 0.76

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues88.088.018.57.594.670.455.826.931.513.4106.428.746.930.67.64.02.6
Cost of Revenues107.710.1339.4330.1240.8159.997.086.189.190.359.946.444.449.535.00.00.0
Gross Profit-19.677.9-320.9-322.6-146.2-89.5-41.1-59.3-57.6-76.946.5-17.72.5-18.8-27.44.02.6
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues17.81.966.81.616.90.50.20.81.70.4
Cost of Revenues2.92.72.399.893.684.679.681.66.382.5
Gross Profit14.9-0.764.5-98.3-76.7-84.1-79.3-80.7-4.7-82.2
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.00.00.00.06.6159.997.086.189.190.359.946.444.449.535.037.238.0
Selling General & Admin Expenses0.00.00.0173.6178.096.852.839.631.336.527.819.717.315.111.713.614.2
Depreciation & Amortization9.99.79.511.911.30.35.35.81.21.90.70.60.50.40.61.31.9
Total Operating Expenses592.6690.2215.3173.6178.096.852.839.631.336.527.819.717.315.111.750.852.2
Operating Income-612.3-612.3-536.2-496.2-324.2-186.3-93.9-98.9-88.9-113.418.7-37.4-14.8-33.9-39.1-48.0-49.6
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.078.60.4
Selling General & Admin Expenses0.00.00.00.00.00.00.00.044.140.1
Depreciation & Amortization2.72.72.32.32.42.42.42.36.31.9
Total Operating Expenses193.3166.0176.057.462.356.750.845.5122.840.1
Operating Income-178.4-166.8-111.5-155.6-139.0-140.8-130.2-126.2-127.4-122.3
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income48.448.451.527.611.30.35.34.54.22.6-2.2-0.10.10.20.10.10.3
Interest Expense103.9103.986.557.751.229.338.727.421.617.02.20.1-0.1-0.2-0.10.10.2
Other Expense-172.7-172.7-53.3-30.0-64.8-29.0-33.3-22.8-17.4-14.4-2.2-0.10.10.20.1-1.20.2
IBT-785.0-785.0-589.5-526.2-389.0-215.3-127.3-121.7-106.3-127.816.5-37.5-14.6-33.7-39.0-47.9-49.5
Income Tax Expense0.00.00.00.013.627.136.827.44.20.7-0.7-0.6-0.5-0.4-0.7-0.2-0.2
Net Income-785.0-785.0-589.5-526.2-402.6-242.4-164.1-149.1-106.3-127.816.5-37.5-14.6-33.7-39.0-47.9-49.3
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income11.510.213.013.715.017.111.67.97.66.8
Interest Expense30.326.324.322.922.622.324.317.317.114.0
Other Expense-4.7-139.4-22.9-5.7-11.0-19.7-13.1-9.4-9.5-7.2
IBT-183.0-306.2-134.4-161.4-150.0-160.5-143.3-135.6-136.9-129.4
Income Tax Expense0.00.00.00.00.00.00.00.01.86.9
Net Income-183.0-306.2-134.4-161.4-150.0-160.5-143.3-135.6-136.9-129.4
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$-5.45$-4.48$-3.15$-2.54$-2.59$-1.95$-2.59$0.41$-0.97$-0.41$-1.24$-2.15$-4.06$-4.61
EPS Diluted$0.00$0.00$0.00$-5.45$-4.48$-3.15$-2.54$-2.59$-1.95$-2.59$0.39$-0.97$-0.41$-1.24$-2.15$-4.06$-4.61
Shares Outstanding122.0120.0112.096.589.876.964.557.654.449.439.938.835.727.318.111.810.7
Diluted Shares Outstanding122.4120.1112.096.589.876.964.557.654.449.442.638.835.727.318.111.810.7
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-1.38$-1.35
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-1.38$-1.35
Shares Outstanding122.0120.0119.5118.5118.1117.7109.2101.999.196.1
Diluted Shares Outstanding122.4120.0119.5118.5118.1117.7109.2101.999.196.1
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents190.594.9113.065.6112.783.036.442.3125.266.965.120.220.214.918.817.5
Short Term Investments866.6981.2501.8717.0359.0381.1188.7156.5143.789.446.463.057.659.130.254.1
Total Cash & ST Investments1,057.21,076.0614.8782.6471.6464.1225.1198.7268.9156.2111.483.277.774.049.071.6
Accounts Receivable0.016.71.30.151.84.45.26.81.10.00.046.60.00.00.00.0
Inventory0.00.00.0-0.1-51.8-4.40.0-6.80.00.00.00.00.00.00.00.0
Other Current Assets10.715.311.912.664.010.23.58.94.32.41.71.31.62.42.11.8
Total Current Assets1,067.81,107.9628.1795.2535.7474.2233.8207.7274.3158.6113.1131.179.376.451.173.5
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents225.574.973.794.946.9190.5120.0113.499.768.6
Short Term Investments737.1783.2864.5981.2964.8866.6499.0501.8439.5497.1
Total Cash & ST Investments962.5858.1938.21,076.01,011.71,057.2619.0615.2539.2565.7
Accounts Receivable1.88.42.016.70.20.00.81.32.51.0
Inventory0.00.00.00.00.00.00.00.0-2.5-1.0
Other Current Assets13.020.015.815.36.710.718.911.919.719.9
Total Current Assets977.3886.5956.11,107.91,018.61,067.8638.7628.1561.4586.6
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment142.9141.0147.7163.2146.422.613.43.23.63.61.81.61.21.01.32.3
Goodwill0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Intangible Assets0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Long-Term Investments305.4145.140.546.7152.137.042.70.016.57.70.20.02.50.00.01.2
Other Long-Term Assets7.77.78.09.77.20.00.00.30.40.20.20.20.10.10.31.0
Total Long-Term Assets456.0293.7196.3219.6305.659.656.13.520.511.52.11.83.91.11.64.5
Total Assets1,523.81,401.7824.31,014.8841.3533.8289.8211.2294.8170.1115.2133.083.277.652.878.0
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment153.6146.3144.6141.0140.6142.9146.2147.7155.5158.1
Goodwill0.00.00.00.00.00.00.00.00.00.0
Intangible Assets0.00.00.00.00.00.00.00.00.00.0
Long-Term Investments288.8178.2150.7145.1269.2305.415.440.515.526.9
Other Long-Term Assets16.814.612.77.77.77.77.88.08.28.3
Total Long-Term Assets459.2339.1308.0293.7417.5456.0169.4196.3179.2193.3
Total Assets1,436.61,225.61,264.11,401.71,436.11,523.8808.1824.3740.6779.9
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable9.520.421.525.621.18.18.23.85.34.22.21.43.72.21.21.1
Short-Term Debt30.030.545.912.814.92.84.62.6-5.32.5-2.2-1.4-3.7-1.40.20.8
Other Current Liabilities63.376.435.346.21.51.01.10.122.918.510.86.812.04.93.25.4
Current Liabilities102.8179.7102.784.671.931.226.022.232.433.331.623.926.75.84.67.3
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable22.116.213.920.411.69.513.021.513.812.6
Short-Term Debt37.934.032.530.530.430.029.845.934.531.4
Other Current Liabilities80.579.560.976.467.9101.646.135.329.521.7
Current Liabilities142.1131.1159.7179.7109.8102.888.9102.777.765.6
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt643.4758.2727.8736.5255.1136.2131.539.831.827.414.60.00.00.00.00.2
Capital Leases116.7131.6138.3139.7127.13.26.80.00.00.00.00.00.00.00.00.0
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Total Liabilities1,415.21,537.01,210.61,122.7597.5420.4300.8185.2185.075.846.640.928.76.14.67.5
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt1,158.9824.1758.5758.2759.3760.1725.2727.8731.2733.6
Capital Leases131.3130.6132.9131.6133.6116.7136.8120.4139.5139.5
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.0
Total Liabilities1,957.71,594.41,530.51,537.01,450.01,415.21,204.21,210.61,179.41,113.0
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock0.10.10.10.10.10.10.1768.80.10.00.00.00.00.10.10.1
Retained Earnings-2,391.2-2,701.8-2,112.2-1,586.0-1,207.6-992.3-865.0-743.3-646.1-518.3-534.7-497.2-482.6-448.9-408.5-360.7
Comprehensive Income-1.02.40.0-3.6-0.90.10.70.50.30.10.10.00.00.00.00.0
Total Common Equity108.6-135.4-386.3-107.9243.9113.4-10.925.9109.894.468.692.154.471.448.270.5
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.10.10.10.10.10.10.10.10.10.1
Retained Earnings-3,303.7-2,997.5-2,863.1-2,701.8-2,551.7-2,391.2-2,247.9-2,112.2-1,975.3-1,845.9
Comprehensive Income0.0-0.21.52.45.4-1.0-0.50.0-0.9-1.5
Total Common Equity-521.1-368.7-266.4-135.4-13.9108.6-396.2-386.3-438.8-333.1
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt790.2788.7755.8749.3269.9138.9136.142.431.827.414.60.00.00.00.00.2
Book Value108.6-135.4-386.3-107.9243.9113.4-10.925.9109.894.468.692.154.471.448.270.5
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value-521.1-368.7-266.4-135.4-13.9108.6-396.2-386.3-438.8-333.1
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income-545.3-785.0-589.5-526.2-389.0-215.3-127.3-121.7-106.3-127.816.5-37.5-14.6-33.7-40.4-47.9-49.3
Depreciation & Amortization12.910.19.511.95.82.31.81.31.21.90.70.60.50.40.61.31.9
Stock-Based Compensation84.40.097.872.147.926.817.610.89.89.07.14.63.33.63.83.14.0
Change Working Capital30.4-35.635.73.1-24.78.589.1-0.3-22.90.512.137.2-34.022.02.6-2.3-1.5
Change In Accounts Receivable1.0-1.1-15.4-1.156.7-47.40.7-2.9-1.1-1.10.046.6-46.60.00.00.00.1
Change In Accounts Payable-3.22.7-4.5-3.54.51.1-0.14.4-1.51.51.70.8-2.21.50.80.2-0.5
Change In Inventories0.00.00.00.00.00.01.5-5.44.9-1.48.22.6-2.60.0-67.5-49.0-67.2
Other Non-cash Items108.2300.450.624.960.532.428.219.117.014.70.50.03.33.6-0.1-47.7-49.3
Cash from Operations-399.10.00.0-414.3-299.5-142.58.9-90.9-101.2-101.837.04.9-44.8-7.7-33.4-45.6-44.8
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-183.0-306.2-134.4-161.4-150.0-160.5-143.3-135.6-136.9-129.4
Depreciation & Amortization2.92.72.32.32.42.42.42.36.31.9
Stock-Based Compensation0.030.727.523.50.025.424.621.619.518.7
Change Working Capital-1.822.5-51.1-5.241.79.99.8-25.744.91.5
Change In Accounts Receivable-16.06.6-6.414.6-16.4-0.20.80.41.2-1.5
Change In Accounts Payable-0.36.61.0-4.65.91.7-1.8-10.37.71.2
Change In Inventories0.00.00.00.00.00.00.00.00.00.0
Other Non-cash Items39.4142.827.49.140.421.47.27.915.411.2
Cash from Operations0.00.00.00.00.00.00.00.0-74.0-96.2
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-0.5-24.8-3.9-1.4-11.3-48.9-11.1-2.6-0.9-2.9-1.6-0.6-1.1-0.5-0.1-0.4-0.5
Acquisitions8.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Investments-1,301.7-1,063.2-1,293.4-635.2-855.4-525.0-435.8-277.9-240.2-240.4-145.2-115.6-107.0-79.4-92.8-48.0-109.9
Sales of Investment676.71,109.6744.2875.9604.6426.1250.4205.8246.2177.594.6132.2104.178.463.973.2143.7
Other Investing Activities-9.80.00.00.00.00.00.00.00.00.00.00.00.00.00.20.60.9
Cash from Investing-627.30.00.0239.3-262.1-147.8-196.5-74.75.1-65.8-52.116.1-4.0-1.5-28.825.334.2
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-5.6-9.4-4.1-5.7-1.3-2.5-1.91.8-0.1-0.2
Acquisitions0.00.00.00.00.00.00.00.081.3-73.3
Investments-350.7-335.5-218.0-164.1-121.1-214.4-815.2-142.7-226.1-117.7
Sales of Investment280.1273.8280.0275.7233.3170.0165.6175.3144.8191.0
Other Investing Activities0.00.00.00.00.00.00.00.0-81.373.3
Cash from Investing0.00.00.00.00.00.00.00.0-81.473.0
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-4.20.00.0-0.9-188.90.00.00.00.00.00.00.00.00.0-0.2-0.8-11.8
Debt Issued45.1788.732.97.3668.3131.02.993.710.64.412.714.60.00.00.10.712.0
Issuance of Common Stock920.50.00.0164.217.5312.0225.136.20.0119.80.08.749.014.543.310.70.4
Repurchase of Common Stock44.40.00.00.017.50.00.00.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Financing Activities405.00.00.057.9670.07.99.0123.613.1106.116.915.20.00.015.111.813.9
Cash from Financing1,147.80.00.0221.3516.2320.0234.1159.813.1225.916.923.948.914.558.321.62.5
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.0-0.2-0.2
Debt Issued1,196.9338.867.02.4-0.9-0.635.3-0.97.5-0.6
Issuance of Common Stock0.00.00.00.00.00.00.00.0162.91.3
Repurchase of Common Stock0.021.30.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.06.153.1
Cash from Financing0.00.00.00.00.00.00.00.0168.854.2
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash121.530.4-18.246.2-45.529.746.6-5.8-83.058.31.844.90.15.3-3.91.3-8.0
Closing Cash Balance190.5125.695.2113.467.2112.783.036.442.3125.266.965.120.220.214.918.817.5
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash-102.9152.02.5-21.248.0-143.370.27.013.331.1
Closing Cash Balance125.6228.676.674.195.247.3190.5120.4113.4100.1
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow-399.5-534.8-399.8-415.7-310.9-191.4-2.1-93.5-102.1-104.635.44.3-45.9-8.3-33.6-46.0-45.3
Real Free Cash Flow-484.0-534.8-497.6-487.8-358.7-218.2-19.7-104.3-111.9-113.728.2-0.2-49.3-11.9-37.3-49.1-49.3
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-148.3-116.9-132.4-137.3-66.9-104.0-101.2-127.8-74.1-96.4
Real Free Cash Flow-148.3-147.6-159.9-160.8-66.9-129.3-125.9-149.4-93.6-115.1
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-9.6-8-1.4
P/S85.8146.79.4
P/B-14.5-8.15.2
P/FCF-12.3-17.2-1.5
Market cap$7.4$4.4
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets83.3 %26.8 %0 %
Debt to Income-152.5 %-67.4 %0 %
Debt to Free cash flow-194.1 %-3761.8 %0 %
Interest expense percentage-17 %-4.7 %44.7 %
Current ratio6.9 8.4 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE150.6 %67.4 %0 %
ROA-54.6 %-41.6 %0 %
CapEx to Revenue23.5 %18.8 %0 %
RaD to Revenue0 %720.7 %0 %
ROEM176,785.1 211930.6

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin-127.5 %-441.7 %68.7 %
Operating margin-656.9 %-1556.9 %35.5 %
Net margin-862.2 %-1677.8 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %-0.2 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding120.0 mil 54.5 mil
Employee count0.5 tis 0.2 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás
Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader